Drug Pipeline
A Q2 2022 Look at Projected Gene Therapies and FDA Approval Timelines More
Briefing
Insights provides context and perspective about key pharmacy trends and issues
Insights offers context and perspective about key pharmacy and health care topics.
Drug Pipeline
Projected Approvals of Pipeline Gene Therapies Expected to Treat Conditions with Few Options More
Briefing
Drug Pipeline
Effective management strategies can help payors manage cost for a range of new treatment options in the drug pipeline. Several medications are nearing approvals for Alzheimer’s, oncology... More
Briefing
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q1 - Q2 2021 More
Specialty Report
Drug Pipeline
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More
Briefing
Drug Pipeline
A range of new treatment options for AD are expected to come to market in the next couple years. Effective management strategies can help payors manage cost. More
Briefing
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q1 - Q2 2021 More
Specialty Report
Drug Pipeline
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More
Briefing
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q4 2020 - Q1 2021 More
Specialty Report
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q3-Q4 2020 More
Specialty Report
Drug Pipeline
Over the past dozen years, several new treatments have come to market with the first oral preventive expected to be approved in December. Targeted management to help balance access and cost... More
Feature